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doi:10.1Objective:Over recent years, a variety of energy sources have been used to replace the traditional incisions of the
Cox maze procedure for the surgical treatment of atrial fibrillation. This study evaluated the safety and efficacy of
a new bipolar radiofrequency ablation device for atrial ablation in a long-term porcine model.
Methods: Six pigs underwent a Cox maze IV procedure on a beating heart off cardiopulmonary bypass using the
AtriCure Isolator II bipolar ablation device (AtriCure, Inc, Cincinnati, Ohio). In addition, 6 pigs underwent me-
dian sternotomy and pericardiotomy alone to serve as a control group. All animals were allowed to survive for 30
days. Each pig underwent induction of atrial fibrillation and was then humanely killed to remove the heart en bloc
for histologic assessment. Magnetic resonance imaging scans were also obtained preoperatively and postopera-
tively to assess atrial and ventricular function, pulmonary vein anatomy, valve function, and coronary artery
patency.
Results: All animals survived the operation. Electrical isolation of the left atrial appendage and the pulmonary
veins was documented by pacing acutely and at 30 days in all animals. No animal that underwent the Cox
maze IV procedure was able to be induced into atrial fibrillation at 30 days postoperatively, compared with all
the sham animals. All 257 ablations examined were discrete, linear, and transmural, with a mean lesion width
of 2.2  1.1 mm and a mean lesion depth of 5.3  3.0 mm.
Conclusions: The AtriCure Isolator II device was able to create reliable long-term transmural lesions of the
modified Cox maze procedure on a beating heart without cardiopulmonary bypass 100% of the time. There
were no discernible effects on ventricular or valvular function. (J Thorac Cardiovasc Surg 2010;140:203-8)In an attempt to treat patients in whom medical treatment for
atrial fibrillation (AF) failed, the Cox maze procedure was
developed two decades ago at our institution.1-3 Introduced
clinically in 1987, the Cox maze III procedure became the
gold standard for the surgical treatment of AF. Although
this ‘‘cut-and-sew’’ procedure had excellent results with
long-term cure rates of over 90%, it was not widely adopted
by most cardiac surgeons owing to its associated morbidity,
technical complexity, and invasiveness.4-9
The introduction of surgical ablation technology over the
past decade has advanced the field of AF surgery tremen-
dously.10-12 Centers around the world have replaced the sur-e Division of Cardiothoracic Surgery, Washington University School of Med-
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Sgical incisions of the Cox maze III with ablation lines on the
atria using a variety of energy sources, simplifying the oper-
ation and making it more accessible to surgeons worldwide.
After extensive investigation, our laboratory has shown
that bipolar radiofrequency (RF) ablation can safely create
reliable transmural lesions and be successfully used to
replace most of the surgical incisions of the original ‘‘cut-
and-sew’’ Cox maze III procedure.13-16 At Washington
University School of Medicine, the bipolar RF ablation–
assisted Cox maze procedure, termed the Cox maze IV,
has clinically replaced the Cox maze III procedure.17 Early
and midterm clinical experience with the Cox maze
IV procedure have shown excellent results, with signifi-
cantly shorter cardiopulmonary bypass and crossclamp
times.18-22 A recent propensity analysis performed by our
group on matched patients who underwent the Cox maze
III versus Cox maze IV procedure found no difference in
freedom from AF recurrence at 1 year.23
The purpose of this study was to evaluate the performance
of a new generation bipolar RF ablation device, the Isolator
II system, developed by AtriCure, Inc (Cincinnati, Ohio). In
a long-term porcine model, a Cox maze IV procedure was
performed.15,16 The Isolator II device was developed in an
attempt to create wider lesions that can be more easily visu-
alized by the surgeon intraoperatively and also to reliablyrdiovascular Surgery c Volume 140, Number 1 203
FIGURE 1. The modified Cox maze procedure lesion set. All lesions were
created off cardiopulmonary bypass using the Atricure Isolator II bipolar ra-
diofrequency ablation device. SVC, Superior vena cava; IVC, inferior vena
cava; RF, radiofrequency.
Abbreviations and Acronyms
AF ¼ atrial fibrillation
EF ¼ ejection fraction
IVC ¼ inferior vena cava
LAA ¼ left atrial appendage
MRI ¼ magnetic resonance imaging
PV ¼ pulmonary vein
RF ¼ radiofrequency
SVC ¼ superior vena cava
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Spenetrate thicker atrial tissue. Several changes in the algo-
rithm of the ablation system and in the mechanical properties
of the device were made in an attempt to make these im-
provements. A sham group (n ¼ 6) of animals was also ex-
amined to determine the effects of a median sternotomy and
pericardotomy alone.METHODS
Experimental Protocol
Twelve domestic pigs weighing 60 to 75 kg were used in this study. All
animals received humane care in compliance with the ‘‘Guide for the Care
and Use of Laboratory Animals,’’ published by the National Institutes of
Health (National Institutes of Health publication 85-23, revised 1985).
The study was also approved by the Washington University School of
Medicine Animal Studies Committee.
Six pigs in the study group underwent preoperative cardiac magnetic
resonance imaging (MRI) under anesthesia to assess left ventricular and
left atrial ejection fractions (EFs), tricuspid and mitral valve function, pul-
monary vein (PV) anatomy and flow, and coronary artery anatomy and
flow. A Cox maze IV procedure was subsequently performed on the beating
heart without cardiopulmonary bypass. The animal was premedicated, intu-
bated, and anesthetized with 2% to 4% isoflurane and was placed on con-
tinuous hemodynamic monitoring throughout the procedure. A median
sternotomy was performed, and the heart was exposed via a pericardiotomy
after administration of amiodarone (150 mg intravenous bolus every hour)
to prevent arrhythmias. The heart was positioned using a suction retractor
(AXIUS Xpose 3; Guidant Corp, Santa Clara, Calif). Baseline pacing
thresholds were obtained from the right and left PVs and at the left atrial
appendage (LAA) using a bipolar pacing device.
The left and right PVs, superior vena cava (SVC), and inferior vena cava
(IVC) were bluntly dissected and isolated using umbilical tapes. The pigs
were fully heparinized (350 units/kg, intravenously), and the activated clot-
ting time was maintained greater than 250 seconds. The Cox maze IV abla-
tion set was performed off cardiopulmonary bypass as previously described
(Figure 1).15 In brief, the right and left PVs were isolated individually, and
a connecting lesion was performed between the right and left PVs. The right
atrial lesion set was then performed via a single atriotomy at the tip of the
right atrial appendage, followed by the SVC and IVC lesions through
a purse-string suture placed midway between the confluence of the SVC
and IVC. The left atrial lesion set was created via an atriotomy on the ante-
rior surface of the LAA. Last, the LAA itself was circumferentially ablated.
The only variation in the Cox maze IV ablation set from our previous
studies was the omission of the right atrial appendage ablation to more
closely mimic the clinical procedure (Figure 1). The ablation lines were pur-
posefully created across the mitral and tricuspid valves and across the right
coronary and circumflex coronary arteries to assess ablation safety. All
ablations were performed a single time only. After completion of the abla-204 The Journal of Thoracic and Cardiovascular Surgtions, electrical isolation was confirmed by pacing distal to the ablation lines
at the right and left PVs and at the LAA. Pacing was performed at the sites
previously documented to capture before ablation. Pacing was performed up
to the maximal output of our stimulator (20 mA) to document exit block.
The pericardium was then closed and the sternum was reapproximated. A
chest tube was placed before sternal closure and was removed during recov-
ery. The entire procedure was completed in approximately 2 hours.
In addition to the study group, 6 pigs underwent median sternotomy and
pericardiotomy alone to serve as the sham group. All animals in both groups
were closely monitored for 48 hours and were allowed to survive for 30
days. Daily aspirin 81 mg by mouth was given, beginning on the first day
after the operation. No antiarrhythmic drugs were administered.
At 30 days postoperatively, the study group underwent a follow-up car-
diac MRI to reassess the cardiac measurements. All animals in both groups
underwent redo median sternotomy. Meticulous adhesiolysis was
performed to expose the entire heart and the PVs. Chronic electrical isola-
tion was confirmed by failure to capture by epicardial pacing (20 mA,
5-ms pulse duration) of the right and left PVs and at the LAA, distal to
the ablation lines. Finally, AF induction was attempted by 2 trials of rapid
pacing from the right atrial free wall for 30 seconds (20 mA, 400 ms, 150
beats/min). If unsuccessful, 2 trials of burst pacing were performed from
the right atrial free wall with 8 S1 at a cycle length of 150 ms followed
by a single extra stimulus S2 of 90 ms. If still unsuccessful, a 2.5-mg bolus
of intravenous neostigmine was given, and the rapid pacing protocol was re-
peated, followed by burst pacing. At the conclusion of the study, the animal
was humanely killed by administering potassium chloride, 80 mEq intrave-
nous bolus, and the heart was removed en bloc for histologic assessment.
Bipolar RF Ablation Device
The bipolar RF ablation system, the AtriCure Isolator II Ablation
System, was used to create the modified Cox maze lesion set in this study
(Figure 2). The ablation instrument consisted of 2 jaws in parallel with op-
posing electrodes, clamped on target tissue during ablation. Energy was
delivered from the ablation and sensing unit to the instrument with an algo-
rithm based on the assessment of tissue conductance every 10th of a second.
This algorithm has been previously described.13,14
The Isolator II Ablation System was designed to create wider ablation
lines that would be easier for the surgeon to visualize when compared
with the original Isolator device. The electrode width remained the same
at 3 mm, but the electrode length on the jaws was slightly shorter with
the Isolator II device (5.3 cm vs 6.4 cm). The mechanical properties of
the clamp were changed to create more even pressure from the heel to theery c July 2010
FIGURE 2. TheAtricure Isolator II device. A, The clampwith a new hand-
piece. B, Close-up view of the jaw of the Atricure Isolator II device.
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Stip of the jaw. This was accomplished by redesigning the handle grip and
shaft into a plunger mechanism for more direct application of pressure.
The algorithm was also changed. The constant current limit (amps) and con-
stant power limit (watts) for this range of tissue conductance was lowered to
slow the ablation time, allowing for resistive heating to reach greater tissue
depth and theoretically allowing for better depth penetration for ablation of
thicker tissue. Although these changes were theoretically beneficial, this de-
vice has not been previously tested in an intact animal.
Histologic and Microscopic Analysis
The excised heart en bloc was grossly examined for any evidence of in-
tra-atrial thrombus formation, PV stenosis, or thrombosis. The heart was
then immediately incubated at room temperature for 45 minutes in 1%
2,3,5-triphenyl-tetrazolium chloride solution. Each bipolar RF lesion was
then sectioned 5-mm apart, perpendicular to the long axis of the ablation
line. The sections were fixed in formalin, molded in paraffin, and sectioned
and stained with hematoxylin and eosin and Masson trichrome stains. Each
section was examined under the microscope to assess the lesion width,
depth, and transmurality. Data are expressed as mean standard deviation.
Cardiac MRI Protocol
Each animal was anesthetized, intubated, placed in a supine position into
a 1.5-T MRI scanner (Philips Medical Systems, Andover, Mass), and fitted
with a 5-element dedicated cardiac surface coil for image reception. Multi-The Journal of Thoracic and Caple anatomic and functional cine images and velocity-encoded images were
obtained using retrospectively gated breath-held balanced turbo field echo
method with parallel imaging as previously described.15 High-resolution
cine loops of the horizontal long-axis, short-axis, and left ventricular out-
flow tract views were obtained during a sequence of breath-holds. Approx-
imately 20 short-axis stacks were generated, 8 mm apart with zero gap,
spanning from the left ventricular apex through the left atrium.
Cardiac MRI Data Analysis
The acquired MRI data were analyzed off-line using a remote Sun Mi-
crosystems workstation running EasyVision analysis software (Philips Re-
lease 5.1). Left atrial and left ventricular volumes were assessed by
planimetry as previously described.15 Left ventricular and left atrial EFs
were defined as ([end-diastolic volume end-systolic volume] divided by
end-diastolic volume).
Transtricuspid and transmitral blood flows were assessed using velocity-
encodedMRI.24MRI was also used to assess anatomic and physiologic flow
patterns in the PV system. Finally, coronary artery anatomy and patency
were assessed using the technique of Botnar and associates,25 which uses
a navigator-gated free-breathing T2-weighted prepared turbo field echo
acquisition.
RESULTS
Operative Results
All animals in both groups survived the operation and the
30-day postoperative period. There was no evidence of post-
operative cardiac arrhythmias, and each animal was in sinus
rhythm during the initial operation and at the time of being
humanely killed. There were no signs of neurologic compli-
cations during the postoperative period.
Acute and Chronic Pacing
Acutely, electrical isolation of the LAA and right and left
PVs was documented by pacing in all 6 animals in the study
group. This was repeated at 30 days after the operation as
well, which also revealed electrical isolation in every
animal. Attempts to induce AF at 30 days were unsuccessful
in all 6 animals. In the sham group, however, AF was induc-
ible in all 6 animals after the protocol described.
Histology
There was no gross evidence of intra-atrial thrombus
formation or stricture of the PVs. The triphenyl-tetrazolium
chloride–stained ablation lines were carefully examined, all
of which appeared linear, pale, discrete lesions over 2 mm in
width.
Microscopic examination of the ablation lines with hema-
toxylin and eosin and Masson trichrome stains revealed
discrete, linear, and pale lesions (Figure 3). A total of 257
samples were examined. Each lesion examined was trans-
mural. The mean overall lesion width was 2.2  1.1 mm,
and the mean lesion depth was 5.3  3.0 mm. The mean le-
sion width in this study was wider than in our previous stud-
ies using the original Isolator device, in which the mean
lesion widths were less than 2 mm.13-15,26 Compared with
our recent study using the Isolator device, the mean ablation
time was slightly longer (9.9  4.6 seconds vs 8.6  3.1rdiovascular Surgery c Volume 140, Number 1 205
FIGURE 3. Gross and microscopic histology. A, Discrete linear ablation
line across the left atrium to the mitral valve. B, Trichrome-stained micro-
scopic histology reveals discrete, transmural lesions across the left atrial
myocardium.
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Sseconds; P ¼ .052), the mean energy delivered during the
ablations was less (89.1  59.4 J versus 109.4  33.5 J; P
¼ .016), and the mean maximal temperature was lower
(46.5C  4.6C vs 51.9C  3.2C; P< .001).15
Histologic examination of the ablated tricuspid and mitral
valve tissue revealed a discrete ablation line without perfora-
tion of the leaflets. The subvalvular apparatus remained in-
tact. There was no identifiable valvular thrombus.
Cardiac MRI Data
Preoperative and 30-day postoperative MRI data were
compared among the 6 animals that underwent the Cox
maze IV procedure. No postoperative PV stenosis was iden-
tified in any animal. Quantitative flow study revealed no sig-
nificant evidence of tricuspid or mitral regurgitation in either
the preoperative or postoperative MRI, with a regurgitant
fraction of less than 5% in every animal. Postoperative
MRI did not detect any coronary artery stenosis or thrombo-
sis in the ablated areas. The right coronary and circumflex206 The Journal of Thoracic and Cardiovascular Surgcoronary arteries were patent in every animal 30 days after
the procedure.
There was no significant difference in the MRI-derived
preoperative versus postoperative left ventricular EF (50%
 12% vs 41%  9%; P ¼ .550). Left atrial contractility
was preserved postoperatively in all animals, as confirmed
by the presence of the a wave, the peak velocity of atrial fill-
ing. However, there was a significant decrease in left atrial
EF postoperatively (23%  10% vs 8%  3%; P ¼ .021).
DISCUSSION
Owing to the advances in surgical ablation technology,
the original ‘‘cut-and-sew’’ Cox maze III is of historical in-
terest only in most centers. Over the past decade, groups
around the world have replaced the original incisions of
the Cox maze III with ablation lines using various energy
sources. These energy sources include cryoablation, RF
energy, microwave, laser, and high-frequency focused ultra-
sound.27 With the exception of RF energy, all other energy
sources have used unipolar sources to create the ablation
lines.
The unipolar energy sources have limitations. These
devices are not capable of indicating when the ablation
results in a transmural lesion. Moreover, many of these
devices were released clinically without accurate dose-
response curves, which has resulted in occasional collateral
cardiac and extracardiac damage.28-30 Furthermore, studies
have shown that unipolar technologies have difficulty creat-
ing transmural lesions when applied epicardially on a beating
heart, limiting their efficacy for less-invasive applications
such as off cardiopulmonary bypass.31-34
Bipolar RF ablation technology has been able to over-
come some of the shortcomings associated with the unipolar
devices.13-16,35 Bipolar RF devices deliver focused energy
between 2 closely approximated electrodes embedded into
the jaws of the clamp, creating discrete linear lesions. The
focused energy reduces the possibility of collateral damage.
Moreover, these devices are capable of measuring the con-
ductance between the 2 electrodes, and algorithms have
been developed that have accurately predicted lesion trans-
murality.13-16 The biggest limitation of bipolar devices is
that they can only ablate atrial tissue that can physically be
clamped within the jaws of the device. This has limited the
lesion sets that can be clinically created, particularly on
the beating heart. For example, bipolar devices have not
been able to create the left and right atrial isthmus lesions
of the Cox maze IV procedure.17
There have been recent efforts to further improve the
bipolar RF ablation devices. Initial clinical experience
from our center showed that a single ablation did not reliably
create conduction block as determined by pacing.18 The
Isolator II device was developed in an attempt to create
wider ablation lines and to reliably penetrate thicker tissue.
The results of this study confirm that the Isolator II deviceery c July 2010
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lator device) and was able to create long-term transmural le-
sions in the beating heart 100% of the time.13-15
The new device was shown not to have any adverse effect
on mitral or tricuspid valve function as measured by MRI
scans. There was no evidence of subacute coronary injury,
PV stenosis, or left atrial thrombus. Furthermore, left ven-
tricular function—as determined by preoperative and post-
operative left ventricular EF—was not affected by the Cox
maze IV procedure performed with the Isolator II device.
The left atrial EF, however, was significantly decreased 30
days after the operation. This has been shown previously
with this lesion set.15
Additional testing of the efficacy of this device showed
that the Cox maze IV lesion set performed with the Isolator
II device was able to prevent the postoperative induction of
AF at 30 days by burst pacing. This was in distinct compar-
ison with the sham group, in which all animals could be
induced into AF at late follow-up.
There are several limitations to this study. The results of
an experimental study must be cautiously applied to the clin-
ical situation. First, there are anatomic differences in the por-
cine and the human heart. Humans have larger PVs with
more surrounding fat. In addition, this study was performed
on normal porcine atria and not on the diseased and often
thickened human atria seen in patients with long-standing
AF. Our early and midterm clinical experience using cardio-
pulmonary bypass, however, has similarly documented the
efficacy of creating transmural lesions with this technol-
ogy.18,19 The Cox maze IV procedure used in this study
involved creating ablations across the right and circumflex
coronary arteries. Although there was no histologic evidence
of thrombosis or stenosis, the follow-up was only 30 days
and does not rule out the possibility of late injury. Therefore,
it is emphasized that ablations should not be performed over
coronary arteries. Finally, a significant limitation for the
clinical use of this beating heart Cox maze IV procedure is
the need to place the clamp inside the atrium. Although
this can be performed without difficulty on the right atrium,
there would be a significant risk of both bleeding and air em-
bolus on the left side and it is not recommended for clinical
use. The use of cardiopulmonary bypass or adjunctive tech-
nology development would be necessary to make this lesion
set feasible on the beating heart.
In conclusion, the Isolator II device was able to reliably
create transmural ablation with a single delivery of energy
in every instance. The performance of the Cox maze IV le-
sion set with this device eliminated the ability to induce
AF. Ablation of valvular tissue produced no discernible
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